Items where Division is "Division of Pharmacology" and Year is 2026

Asadpour, A. (2026) Effects of secretome and EVs from neural crest-derived stem cells on glioblastoma multiforme cells. PhD thesis, University of Reading. doi: 10.48683/1926.00128572

Asadpour, A., Cottrell, G. S. ORCID: https://orcid.org/0000-0001-9098-7627 and Widera, D. ORCID: https://orcid.org/0000-0003-1686-130X (2026) Pro- and Anti-tumorigenic effects of MSC secretome in Glioblastoma: mechanisms and therapeutic implications. Stem cell reviews and reports. ISSN 1558-6804 doi: 10.1007/s12015-026-11082-z (In Press)

Desborough, M. J. R., Mitchell, J. L., Whitworth, P., Al Juwaiser, A., Sage, T., Kriek, N., Little, G. ORCID: https://orcid.org/0000-0001-9810-4358, Vaiyapuri, S. ORCID: https://orcid.org/0000-0002-6006-6517, Gibbins, J. M. ORCID: https://orcid.org/0000-0002-0372-5352 and Bye, A. P. ORCID: https://orcid.org/0000-0002-2061-2253 (2026) Recombinant von Willebrand Factor (vonicog alfa) reduces platelet inhibition caused by antiplatelet drugs and has potential as an acute haemostatic agent. Haematologica. ISSN 1592-8721 (In Press)

Papapetropoulos, A., Topouzis, S., Alexander, S. P. H., Cortese-Krott, M. M., Helyes, Z., Martemyanov, K., Mauro, C., Nagercoil, N., Panettieri Jr, R. A., Patel, H. H., Schulz, R., Stefanska, B., Stephens, G. J. ORCID: https://orcid.org/0000-0002-8966-4238, Vergnolle, N., Wang, X., Ward, S. and Ferdinandy, P. (2026) Novel drugs approved by the EMA, the FDA and the MHRA in 2025: a year in review. British Journal of Pharmacology. ISSN 1476-5381 doi: 10.1111/bph.70376

Schofield, A. L., Notari, E., Rožňovcová, M. ORCID: https://orcid.org/0000-0001-6638-5511, Cox, K. W., D’Aloisio, V., Steuer, C., Michel, J., Cottrell, G. S. ORCID: https://orcid.org/0000-0001-9098-7627 and Coxon, C. R. (2026) Computational design, synthesis and evaluation of stapled peptide-based antagonists of the CGRP receptor. Journal of Medicinal Chemistry. ISSN 0022-2623 doi: 10.1021/acs.jmedchem.5c03445 (In Press)